As of April 16, 2025, Harmony Biosciences (HRMY) has a market cap of $1.65 billion USD. According to our data, Harmony Biosciences is ranked No.4278 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.65 B |
-15.93%
|
Dec 31, 2024 | $1.96 B |
6.53%
|
Dec 29, 2023 | $1.84 B |
-41.38%
|
Dec 30, 2022 | $3.14 B |
29.22%
|
Dec 31, 2021 | $2.43 B |
17.95%
|
Dec 31, 2020 | $2.06 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Avadel Pharmaceuticals
AVDL
|
$0.76 B |
0.000 M
|
![]() Ireland
|
![]() Axsome Therapeutics
AXSM
|
$5.06 B |
-0.000 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
Market Cap | = | HRMY Stock Price | * | HRMY Shares Outstanding |
= | $28.75 | * | 57.39 M | |
= | $1.65 B |